|
Mar 28
|
Utah Medical Products Full Year 2024 Earnings: EPS: US$3.96 (vs US$4.58 in FY 2023)
|
|
Aug 29
|
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
|
|
Aug 28
|
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
|
|
Jul 27
|
Utah Medical Products Second Quarter 2024 Earnings: EPS: US$0.98 (vs US$1.16 in 2Q 2023)
|
|
Jul 26
|
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales
|
|
Jul 25
|
Utah Medical: Q2 Earnings Snapshot
|
|
Jul 25
|
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
|
|
Jul 12
|
Capital Allocation Trends At Utah Medical Products (NASDAQ:UTMD) Aren't Ideal
|
|
Jun 21
|
Investors in Utah Medical Products (NASDAQ:UTMD) have unfortunately lost 27% over the last year
|
|
May 31
|
With 65% ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) boasts of strong institutional backing
|
|
May 28
|
Zacks Initiates Coverage of UTMD With Neutral Recommendation
|
|
Dec 13
|
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
|
|
Dec 9
|
Utah Medical Products, Inc. (NASDAQ:UTMD) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
|
|
Dec 6
|
Utah Medical Products (NASDAQ:UTMD) shareholders have endured a 15% loss from investing in the stock a year ago
|